首页 › 股票 › XAGEW

XAGEW — CARMELL THERAPEUTICS CORP

申报持仓市值$32.49M
持有基金数(最新)20
板块—

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q3 2026)1
机构持仓市值$10 · 2.79K 股
新建/增持/减仓/清仓0 / 0 / 0 / 0 · 更新于 2026-11-17
前五大/前十大集中度100.0% / 100.0%
机构整体持仓变动 增持 +0.0% (+0 股)
机构持仓市值变动 下降 -28.6%

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

截至Q3 2026,共 1 家机构在其最新 13F 申报中持有 XAGEW(CARMELL THERAPEUTICS CORP),合计申报市值 $10,对应 2.79K 股。按股数计算较上季度增持 0.0%(+0 股),申报市值环比下降 28.6%。持仓集中度较高:前五大持有人占申报市值的 100.0%,前十大的集中度为 100.0%。

CARMELL THERAPEUTICS CORP(XAGEW)的主要机构持有人包括 PERISCOPE CAPITAL INC.、DeepCurrents Investment Group LLC、HIGHBRIDGE CAPITAL MANAGEMENT LLC,按 13F 申报市值在本页 20 家持有人中排名居前。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 1 2.79K $10 +0.0%
Q2 2026 1 2.79K $14 +0.0%
Q1 2026 1 2.79K $10 +0.0%
Q4 2025 1 2.79K $24 +0.0%
Q3 2025 1 2.79K $43 +0.0%
Q2 2025 12 2.17M $60.60K -1.6%
Q1 2025 12 1.83M $59.55K -0.1%
Q4 2024 13 1.88M $101.25K -2.5%

表内 8 个季度中,机构持股合计减少 100%(Q4 2024 → Q3 2026)。

前 25 大机构持仓人(Q3 2026) — 1 家基金

基金股数金额组合权重变化
Ancora Advisors LLC 2.79K $10 0.00% 持有

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 1 家基金

基金股数金额组合权重变化
Ancora Advisors LLC 2.79K $14 0.00% 持有

Q1 2026 — 1 家基金

基金股数金额组合权重变化
Ancora Advisors LLC 2.79K $10 0.00% 持有

Q4 2025 — 1 家基金

基金股数金额组合权重变化
Ancora Advisors LLC 2.79K $24 0.00% 持有

Q3 2025 — 1 家基金

基金股数金额组合权重变化
Ancora Advisors LLC 2.79K $43 0.00% 持有

Q2 2025 — 12 家基金

基金股数金额组合权重变化
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM 371.25K $11.29K 0.00% 持有
TORONTO DOMINION BANK 365.07K $11.10K 0.00% 新进
LINDEN ADVISORS LP 371.25K $9.95K 0.00% 持有
Balyasny Asset Management 342.71K $7.95K 0.00% 持有
Sculptor Capital LP 228.30K $6.12K 0.00% 持有
MILLENNIUM MANAGEMENT LLC 188.54K $5.73K 0.00% 持有
Millennium Management 188.54K $5.73K 0.00% 持有
AQR Arbitrage LLC 45.58K $1.06K 0.00% 减持
Citadel Advisors 44.01K $1.02K 0.00% 减持
Saba Capital Management, L.P. 19.60K $525 0.00% 持有
Ancora Advisors LLC 2.79K $85 0.00% 持有
UBS Group AG 1.40K $42 0.00% 减持

新建仓(Q3 2026)

本季度没有基金新建该仓位。

完全清仓(较上季)

本季度没有被追踪基金完全清仓。

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Ancora Advisors LLC 2.79K 2.79K 2.79K 2.79K 2.79K 2.79K 2.79K 2.79K 2.79K 2.79K 2.79K 2.79K 2.79K
LINDEN ADVISORS LP — — — — — 371.25K 371.25K 371.25K 371.25K 371.25K 371.25K 371.25K 371.25K
PERISCOPE CAPITAL INC. — — — — — — — — — — 195.99K 240.27K 242.87K
HIGHBRIDGE CAPITAL MANAGEMENT LLC — — — — — — — — 213.91K 213.91K 181.82K 181.82K 181.82K
WHITEBOX ADVISORS LLC — — — — — — — — 18.75K 18.75K 18.75K 18.75K 18.75K
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM — — — — — 371.25K 371.25K 371.25K 371.25K — — 371.25K 371.25K
Balyasny Asset Management — — — — — 342.71K 342.71K 342.71K 342.71K 342.71K 342.71K 342.71K 342.71K
MILLENNIUM MANAGEMENT LLC — — — — — 188.54K 188.54K 188.54K 188.54K 188.54K 190.44K 234.89K 237.47K
Sculptor Capital LP — — — — — 228.30K 228.30K 228.30K 228.30K 228.30K 228.30K 228.30K 228.30K
DeepCurrents Investment Group LLC — — — — — — — — — — — — 8.75K
AQR Arbitrage LLC — — — — — 45.58K 61.13K 74.39K 79.88K 81.05K 85.58K 96.03K 96.64K
Citadel Advisors — — — — — 44.01K 45.77K 46.84K 75.37K 76.16K 98.47K — —
Walleye Capital LLC — — — — — — — 45.35K 50.95K 50.95K 50.95K 50.95K 50.95K
TORONTO DOMINION BANK — — — — — 365.07K — — — — — — —
Saba Capital Management, L.P. — — — — — 19.60K 19.60K 19.60K 19.60K 19.60K 19.60K 19.60K 19.60K
FLOW TRADERS U.S. LLC — — — — — — — — — — — 20.19K 20.49K
WOLVERINE ASSET MANAGEMENT LLC — — — — — — — — 584 4.59K 9.41K 10.66K 6.21K
UBS Group AG — — — — — 1.40K 12.69K 116 8.98K 131 — — 2.71K
Bank of America Corp — — — — — — 200 100 100 100 100 — —
Millennium Management — — — — — 188.54K 188.54K 188.54K 188.54K 188.54K 190.44K 234.89K 237.47K

下载持有人名单 (CSV)

常见问题

Which funds hold XAGEW?

As of 2026-Q3, 1 institutional funds reported holding XAGEW (CARMELL THERAPEUTICS CORP) in SEC 13F filings, with a combined reported value of $10.

How many shares of XAGEW do institutions own?

13F filers reported 2.79K shares of XAGEW, worth $10 in aggregate at the end of 2026-Q3.

Is institutional ownership of XAGEW rising or falling?

Share counts moved +0.0% versus the prior quarter — accumulation.

Who are the top institutional holders of XAGEW?

The largest 13F holders are PERISCOPE CAPITAL INC., DeepCurrents Investment Group LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM, TORONTO DOMINION BANK; the top 25 are ranked at the top of this page.

Who are the major shareholders of CARMELL THERAPEUTICS CORP?

The major shareholders of CARMELL THERAPEUTICS CORP (XAGEW) by reported 13F value are PERISCOPE CAPITAL INC., DeepCurrents Investment Group LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM, TORONTO DOMINION BANK, among 20 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 XAGEW」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/XAGEW/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →